These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1351 related articles for article (PubMed ID: 26892153)

  • 1. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
    Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS
    Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.
    Lalwani N; Prasad SR; Vikram R; Shanbhogue AK; Huettner PC; Fasih N
    Radiographics; 2011; 31(3):625-46. PubMed ID: 21571648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
    Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
    Kurman RJ; Shih IeM
    Hum Pathol; 2011 Jul; 42(7):918-31. PubMed ID: 21683865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data.
    Gilks CB
    Int J Gynecol Pathol; 2004 Jul; 23(3):200-5. PubMed ID: 15213595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis in type I epithelial ovarian cancer.
    Sadłecki P; Walentowicz-Sadłecka M; Grabiec M
    Ginekol Pol; 2017; 88(12):692-697. PubMed ID: 29303228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origins and molecular pathology of ovarian cancer.
    Bell DA
    Mod Pathol; 2005 Feb; 18 Suppl 2():S19-32. PubMed ID: 15761464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous carcinoma.
    Jain A; Seiden MV
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
    Dehari R; Kurman RJ; Logani S; Shih IeM
    Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
    Kurman RJ; Shih IeM
    Am J Surg Pathol; 2010 Mar; 34(3):433-43. PubMed ID: 20154587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory role of prohibitin in human ovarian epithelial cancer.
    Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX
    Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J; McCluggage WG
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox10 expression in ovarian epithelial tumors is associated with poor overall survival.
    Kwon AY; Heo I; Lee HJ; Kim G; Kang H; Heo JH; Kim TH; An HJ
    Virchows Arch; 2016 May; 468(5):597-605. PubMed ID: 26951260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathology of Ovarian Epithelial Neoplasms: Predictive, Prognostic, and Emerging Biomarkers.
    Ordulu Z; Watkins J; Ritterhouse LL
    Clin Lab Med; 2024 Jun; 44(2):199-219. PubMed ID: 38821641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.